All In MedTech

Device Trial Radar · NCT04002479

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

37

Planned (sponsor's estimate)

Start

Mar 31, 2023

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Alpha Tau Medical LTD.Not on our public-company list
Sponsor type
Industry
First posted
Jun 28, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer.

Conditions

  • Pancreatic Cancer
  • Unresectable Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Pancreatic Adenocarcinoma

Interventions

  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)Device

    An intratumoral insertion of radioactive sources \[Ra-224 containing stainless-steel 316LVM tubes- (Alpha DaRT seeds)\]. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Feasibility - DaRT seed placementTime frame: Day 0 (Day of insertion)
  2. Safety - Adverse eventsTime frame: 3 months
  3. Safety - Adverse eventsTime frame: 3 to 24 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Centre Hospitalier de l'Université de Montréal (CHUM)

    Montreal, Quebec, Canada

  • Jewish General Hospital

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.